- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies ; volume:17 ; number:1 ; day:8 ; month:11 ; year:2022 ; pages:1-26 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (8.11.2022), 1-26, 12.2022
- Urheber
-
Raulin, Ana-Caroline
Doss, Sydney V.
Trottier, Zachary A.
Ikezu, Tadafumi C.
Bu, Guojun
Liu, Chia-Chen
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00574-4
- URN
-
urn:nbn:de:101:1-2023012209390053289021
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raulin, Ana-Caroline
- Doss, Sydney V.
- Trottier, Zachary A.
- Ikezu, Tadafumi C.
- Bu, Guojun
- Liu, Chia-Chen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
ApoE4: an emerging therapeutic target for Alzheimer’s disease
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
APOE effects on regional tau in preclinical Alzheimer’s disease
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease
Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
ApoE4: an emerging therapeutic target for Alzheimer’s disease
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
APOE effects on regional tau in preclinical Alzheimer’s disease
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease
Vascular hypothesis of Alzheimer’s disease: role of apoE and apoE receptors
ApoE4: an emerging therapeutic target for Alzheimer’s disease
ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
APOE effects on regional tau in preclinical Alzheimer’s disease
Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential
α-synuclein in the pathophysiology of Alzheimer’s disease
BACE inhibition-dependent repair of Alzheimer’s disease pathophysiology
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease